A. Lovqvist et al., BINDING, INTERNALIZATION AND EXCRETION OF TGF-ALPHA-DEXTRAN ASSOCIATED RADIOACTIVITY IN CULTURED HUMAN GLIOMA-CELLS, Cancer biotherapy, 8(4), 1993, pp. 345-356
Conjugates based on transforming growth factor alpha, TGFalpha, or epi
dermal growth factor, EGF, are candidates for targeted radiotherapy ag
ainst EGF-receptor rich tumours such as gliomas or squamous carcinomas
. In this study, binding, internalization and excretion of radiolabell
ed TGFalpha and TGFalpha-dextran conjugates was analysed in an EGF-rec
eptor rich human glioma cell line. The binding of I-125-TGFalpha was E
GF-receptor specific and the binding pattern was similar to that of I-
125-EGF. The TGFalpha-dextran conjugate also bound specifically but ga
ve maximum binding for a longer time during continuous incubation comp
ared to when only TGFalpha was used. The excretion pattern of internal
ized radioactivity was somewhat slower for I-125-TGFalpha-dextran, wit
h I-125-labelling on the TGFalpha part, as compared to I-125-TGFalpha
although most of the radioactivity in both cases was excreted within 4
hours. The fate of the dextran part of the conjugate, as followed by
means of I-125-labelling of the dextran, was different since all radio
activity in that case remained cell-associated for at least up to 22 h
ours. Furthermore, by comparison with previously published results, it
was seen that the radioactivity delivered through the TGFalpha part o
f TGFalpha-dextran was retained for a shorter period of time by the ce
lls than when delivered by EGF in EGF-dextran conjugates. However, whe
n the radioactivity was delivered by the dextran part of the conjugate
s, the radioactivity seemed to be retained equally well or even better
when TGFalpha-dextran was applied It is concluded that TGFalpha-dextr
an, as well as EGF-dextran, have interesting properties for targeting
against EGF-receptors and that the dextran part is well retained in th
e cells and therefore might be a suitable carrier for toxic agents suc
h as radionuclides. It is of high interest to continue with toxicologi
cal and pharmacological in vivo studies of the conjugates.